Formulation, Characterization and In Vitro Skin Penetration of Green tea (Camellia sinensis L.) Leaves Extract-Loaded Solid Lipid Nanoparticles

Size: px
Start display at page:

Download "Formulation, Characterization and In Vitro Skin Penetration of Green tea (Camellia sinensis L.) Leaves Extract-Loaded Solid Lipid Nanoparticles"

Transcription

1 Journal of Applied Pharmaceutical Science Vol. 8(08), pp , August, 2018 Available online at DOI: /JAPS ISSN Formulation, Characterization and In Vitro Skin Penetration of Green tea (Camellia sinensis L.) Leaves Extract-Loaded Solid Lipid Nanoparticles Selvina Dzulhi 1, Effionora Anwar 2*, Tati Nurhayati 3 1 National Agency of Drug and Food Control of Republic of Indonesia, Central Jakarta 10560, Special Capital Region of Jakarta, Indonesia. 2 Department of Pharmaceutical Technology, Faculty of Pharmacy, Universitas Indonesia, Depok West Java, Indonesia. 3 Department of Aquatic Products Technology, Faculty of Fisheries and Marine Sciences, Bogor Agricultural University, Bogor West Java, Indonesia. ARTICLE INFO Article history: Received on: 05/12/2017 Accepted on: 27/06/2018 Available online: 31/08/2018 Key words: solid lipid nanoparticle (SLN), Camellia sinensis, skin penetration, solvent emulsification, green tea, epigallocatechin gallate (EGCG). ABSTRACT Purpose: This study aims to formulate and evaluate the characteristics and the skin penetration of green tea leaves extract loaded solid lipid nanoparticles (GT-SLN). Methods: GT-SLN was prepared by solvent emulsificationevaporation method. The properties of SLN were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and in vitro penetration studies were investigated with Franz diffusion cells. Results: The GT-SLN1 presented spherical shape with an average particle size of ± nm; polydispersity index of ± 0.05; zeta potential of ± 1.29; entrapment efficiency of ± 0.443%. In vitro penetration study with Franz diffusion cell showed flux value from GT-SLN1 of ± μg/cm 2.hour and GT ± μg/cm 2.hour. Conclusion: In vitro skin penetration study showed that solid lipid nanoparticles improved the penetration of epigallocatechin gallate (EGCG) through the stratum corneum. INTRODUCTION Green tea has become a popular drink and often consumes widely in Indonesia. Green tea is produced by drying young fresh leaves from Camellia sinensis L. plant. The green tea leaves extract has a major component of polyphenols. Polyphenols are known to have even higher potent antioxidant activity compared with vitamin E and vitamin C (Jigisha et al., 2012). Green tea leaves extract also has the ability to inhibit the tyrosinase enzyme (Gillbro et al., 2011). Polyphenols from green tea potent as free radical binders due to hydroxyl groups in their chemical structure. The main flavonoids in green tea are catechins, with a content of 25-35% of the dry weight of green tea leaves (Aafrin, 2013). * Corresponding Author Effionora Anwar, Department of Pharmaceutical Technology, Faculty of Pharmacy, Universitas Indonesia, Depok West Java, Indonesia. farmasi.ui.ac.id The four catechin compounds found in green tea are epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin gallate. Epigallocatechin gallate is the largest compound of all, about 59% of total catechins (Sinija and Mishra, 2008; Krishnaveni, 2012). Epigallocatechin gallate must be able to penetrate into the skin in order to provide optimal antioxidant and tyrosinase activity. Epigallocatechin gallate has a hydrophilic property with a water solubility of g/l, partition coefficient (Log P) of 0.48 (Patel and Velikov, 2013), molecular weight , and unstable at a high temperature (>50 C), and alkaline ph (ph > 8) (Namal, 2013). Some research studies suggest that catechins have low penetration ability due to its hydrophilic properties and also because of chemical interactions with skin lipid bilayer (Scalia et al., 2014; Sun et al., 2009). Therefore, an effort is needed to overcome the problem, one of it is using the carrier system in such as solid lipid nanoparticles. Solid lipid nanoparticles (SLN) is colloidal 2018 Selvina Dzulhi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License -NonCommercial- ShareAlikeUnported License (

2 058 Dzulhi et al. / Journal of Applied Pharmaceutical Science 8 (08); 2018: nanoparticulate system which is composed of biocompatible and biodegradable materials in the nanometer size range with an average particle size of nm (Müller et al., 2002; Balguri et al., 2016). SLN is made of solid lipid with a concentration of % (w/w), surfactant with a concentration of 0.5-5% (w/w), and water (Pardeike et al., 2009). The quality of SLN dispersion is influenced by the selection of ingredients and the concentration of lipids and surfactants as emulsifiers (Mehnert and Mader, 2012). The advantages of SLN in cosmetic preparations are high occlusion properties that can increase the penetration of active substances through the stratum corneum on the skin, able to improve the stability of the active compounds by protecting from degradation and increase skin hydration so that able to enhance skin penetration. In this study, green tea leaves extract was made in SLN dosage form using solvent emulsification-evaporation method. Green tea leaves extract SLN was prepared with variations of concentration of solid lipids and performed SLN characterization obtained. In order to see the impact of creating SLN for green tea leaves extract, penetration test was çonducted on female rats skin using Franz diffusion cell. MATERIALS AND METHOD Materials Green tea (Camellia sinensis L.) leaves extract was purchased from Andy Biotech (Xi an Co Ltd, Cina), epigallocatechin gallate standard (Sigma-Aldrich), glyceryl monostearate (Cutina, was kindly provided by BASF), lecithin (phospholipon 90G, Lipoid), poloxamer 188 (Pluracare F68 G, was kindly provided by BASF), potassium dihydrogen phosphate (Merck), sodium hydroxide pellets for analysis (Merck), ethanol absolute for analysis (Merck), dichloromethane (Merck), demineralized water (Brataco), and Female Sprague- Dawley rats aged 2-3 months with average weight 200 grams (Bogor Agricultural University, Indonesia). Preparation of GT-SLN SLN was prepared by modified solvent emulsificationevaporation method referring to Kelidari et al. (2015). Green tea leaves extract powder was dissolved in 3 ml ethanol, then glyceryl monostearate (GMS) and lecithin were dissolved in 10 ml dichloromethane (DCM). Both solutions were mixed using a homogenizer (Edmund Buhler D-7400 Tubingen) at 30,000 rpm for 15 minutes. Poloxamer 188 was added to the mixture then homogenized at 30,000 rpm for 15 minutes. The SLN forming process was continued by evaporating the organic solvent (DCM) with a magnetic stirrer (3,000 rpm) for 3 hours under a fume hood at room temperature. Particle characterization Particle size and polydispersity index (PDI) of SLN was determined by Particle Size Analyzer (PSA) with dynamic light scattering (DLS) method. DLS measurements were performed at 90 light scattering and temperatures of 25 C ± 0.1 C. Suspension of SLN was diluted in demineralized water and filtered using a 0.2 µm filter membrane. Particle size, PDI and zeta potential (ZP) were measured using a Zeta Sizer Nano-ZS (Malvern Instruments, Malvern, UK). Transmission electron microscopy (TEM) Morphology and form of SLN were observed with a transmission electron microscope (TEM). Samples were added with 2% phosphotungstic acid and placed on a copper grid to be observed using TEM. Differential scanning calorimetry (DSC) DSC was used to determine the thermal properties. Samples were packaged in aluminum under nitrogen, with a heating rate of 10 C/min and evaluated at 20 to 200 C temperature intervals. DSC analysis was performed on green tea leaves extract powder, GMS powder, a physical mixture of green tea leaves extract-gms, and GT-SLN with DSC (DSC60, Shimadzu, Japan). Entrapment efficiency The entrapment efficiency of SLN suspension was determined by the centrifugation method based on Kelidari et al. (2015) with modification. The SLN suspension was inserted into a centrifugation tube, then the sample is centrifuged at 9,000 rpm for 1.5 hours. The supernatant was then diluted with mobile phase, consisted of acetic acid (0.05%, v/v): acetonitrile (87:13, v/v), then filtered with 0.45 μm filter membrane and then analyzed using HPLC Shimadzu LC-20AD with the C-18 column (Waters, XBridge ), flow rate of 1.0 ml/min and detected at 280 nm through a UV detector. The injection volume was 20 μl and a total running time of 12 min with the column temperature at 25 C. Peak area was measured as the value of free EGCG. Entrapment efficiency (%EE) is determined using the following Eq. (1): %EE = ((W i W f )/W i ) 100%, (1) where W i is the total amount of drug added in the formulation and W f is the amount of free drug in the supernatant. In vitro skin penetration study Skin penetration test by Franz diffusion cells method has been approved by the Ethics Committee of the Faculty of Medicine, Universitas Indonesia with approval number 390/UN2. F1/ETIK/2017. In order to perform in vitro skin penetration study, each GT-SLN and GT was made into a cream dosage form. The membrane used in this study was the abdominal skin of Sprague Dawley female rats, aged 2-3 months with an average weight of 200 g. Ether was used to anesthetic the Rat. The abdominal part was shaved carefully, and the abdominal skin is slashed and the subcutaneous fat removed thoroughly. The abdominal skin then was immersed in phosphate buffer ph 5.5 for 30 min before storing at 4 C. The skin can be used within 24 hours. In vitro penetration study was performed using Franz diffusion cells with membrane area 1.76 cm 2. The receptor compartment was filled with a 15 ml of phosphate buffer (ph 5.5) and maintained at 37 ± 1 C and stirred with a magnetic stirrer at 300 rpm. The skin was placed between the donor compartment and the receptor compartment with the stratum corneum position facing upward. Approximately 1 g of sample was applied to the skin surface. Then, at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 h, samples were taken 3.0 ml from receptor compartment using a syringe and immediately replaced with phosphate buffer ph 5.5 with the similar volume. Each sample was taken from triplicates. Samples were analyzed with HPLC as described before.

3 Dzulhi et al. / Journal of Applied Pharmaceutical Science 8 (08); 2018: The cumulative amount (Q) of samples penetrated per diffusion area (µg/cm 2 ) was calculated by Eq. (2) (Thakker and Chern, 2003): Q = cumulative amount of EGCG penetrated per area of diffusion (µg/cm 2 ). Cn = concentration of EGCG (µg/ml) on the nth sampling interval. V = volume of Franz diffusion cell. = the amount of EGCG (µg/ml) concentration in the first sampling until before the n th minute. S = sample volume (µl). A = area of membrane (cm 2 ). For this research, the area of the membrane was 1.76 cm 2. The calculation of flux (J) of drug was performed using equations based on Fick I law: J = M/(S t). Where: J is the flux (μg.cm 2.hour 1 ), M is the cumulative amount of EGCG through the membrane (μg), S is the area of diffusion (cm 2 ) and t is time (hours). Furthermore, a graph of the cumulative amount of EGCG penetrated (μg) per area of diffusion (cm 2 ) was made with time (hours). The slope of this curve was the flux value. RESULTS AND DISCUSSION SLN preparation and characterization The chosen method for SLN preparation was solvent emulsification-evaporation (Mehnert and Mader, 2012). The advantages of such method are do not require heating, easy to (2) use in avoiding the active ingredient from direct light, and able to produce small particle size 24 nm (Ganesan and Narayanasamy, 2017; Mäder et al., 2001), hence it is able to protect the active substance from degradation and oxidation during the SLN manufacturing process (Katz et al., 2015; Pardeike et al., 2009). The SLN preparation using a solvent emulsificationevaporation method was based on lipid precipitation in o/w emulsion, the oil phase was dissolved in a water-immiscible organic solvent, then was dispersed into the aqueous phase with a surfactant to form o/w emulsion (Mehnert and Mader, 2012). In this study, SLNs were made using a combination of glyceryl monostearate (GMS) used at 1% and 2% w/w with a combination of EGCG concentrations of green tea extract equivalent to 1% and 2% w/w. At the beginning of SLN manufacture, the green tea leaves extract was dissolved in 3 ml ethanol in order to solubilize EGCG in the oil phase, while lecithin and glyceryl monostearate were dissolved in an insoluble organic solvent of 10 ml dichloromethane. Subsequently, the EGCG solution was mixed using a homogenizer at a speed of 30,000 rpm for 15 minutes. In the SLN formulation, it is necessary to add a surfactant in order to stabilize and inhibit the agglomeration of dispersed fatty globules. The selected surfactant, 4% poloxamer 188, was able to form an emulsion with a lower particle size and greater entrapment efficiency (Ekambaram and Abdul Hasan Sathali, 2011). Using a combination of surfactant (Phospholipon 90G and Poloxamer 188) is able to improve stability during storage and able to create a smaller particle size (Mehnert and Mader, 2012). Fig. 1: Particle Size Distribution of GT-SLN1.

4 060 Dzulhi et al. / Journal of Applied Pharmaceutical Science 8 (08); 2018: Table 1: Formulation and Characterization of GT-SLN. Formulation EGCG (%, w/w) GMS (%, w/w) Lecithin (%, w/w) Poloxamer 188 (%, w/w) Water (g) Size (nm) PDI ZP (mv) EE% GT-SLN qs ± ± ± ± GT-SLN qs ± ± ± ± GT-SLN qs ± ± ± ± GT-SLN qs ± ± ± ± Note: all values were represented as mean ± S.D (n = 3). Based on particle size and particle size distribution characterization from SLN formula, the result of GT-SLN1 had the smallest particle size that is ± nm with a polydispersity index of ± 0.05 (Fig. 1). The addition of 2% GMS on the GT-SLN2 formula was resulted in larger particle size than GT-SLN1 (178.4 ± 1.11 nm). Based on the result of particle size, it can be seen that there is an effect of the GMS lipid addition on the SLN formula. Increasing amount of lipids can make greater particle size because it will increase the interface stress, therefore the lipid will agglomerate and produce a larger particle size. The result of polydispersity index analysis of SLN formula, obtained PDI value 0,5 indicating that all SLN formulas had homogeneous particle size distribution. The smaller PDI value indicates the more homogeneous particle size distribution. The particle size and PDI measurements from SLN can be seen in Table 1. Zeta potential measurement was made to predict the stability of SLN during storage. In general, particle aggregation tends to occur on charged particles. Positive or negative zeta potential values indicate the greater repulsive force of the charged particles, the less likely it is for the particles to aggregate. A good potential zeta value is above +30 mv or below 30 mv (Jose et al., 2014), while zeta potential 15 mv indicates the beginning of the gelation phenomenon (Mäder et al., 2001). The result of the zeta potential of SLN formula can be seen in Table 1. The result showed that all SLN formula had zeta potential below 30 mv which means it tends to be stable at the storage time and there is no gelation phenomenon. TEM analysis Fig. 2 shows the particle morphological form of the formula GT-SLN1. Particle morphology was analyzed using TEM imaging technique. Based on analysis of TEM showed that GT-SLN1 particle was a spherical shape. Entrapment efficiency (EE) The results of entrapment efficiency on all SLN formulas were ranged from ± 0.443% to ± 0.222%. This research showed that increasing lipid concentration will increase entrapment efficiency since increasing lipid matrix will cause more space for the active substance to incorporate in the SLN. An increase in lipid levels may also reduce the release of the drug to an external phase, which may lead to increase entrapment efficiency (Jose et al., 2014) because of its low half-life (<0.25 h. Similarly, studies were done by Kelidari et al. (2015) and Akbari et al. (2016) proof that the greater composition of lipids will enhance the entrapment efficiency of the drug. The result of the entrapment efficiency can be seen in Table 1. Fig. 2: TEM image of green tea leaves extract loaded SLN (GT-SLN1) with magnification. Differential scanning calorimetry (DSC) analysis The result of DSC analysis from GT powder showed that there were several peaks of a melting point such as C with enthalpy value J/g and C with enthalpy value J/g showing an endothermic reaction (see Fig. 3). For GMS powder, the results of DSC with peak melting point of C. In the physical mixture of GT-GMS, DSC results with peak melting point between 67.8 C and C. From this DSC result, there was no significant melting point between GMS with a physical mixture of GT-GMS. The results of the DSC GT-SLN analysis showed an endothermic reaction with a melting point of C and an enthalpy value of J/g. These results were at the peak of the endothermic around the GMS melting point, but the peak of the endotherm of the GT was not visible. The possible cause is that solid lipids can inhibit crystallization of the active substance during nanoparticle formation. This is due to the active substances dissolved in the liquid lipid matrix resulting in the conversion of the active substance from the crystalline form to the amorphous form (Kelidari et al., 2015; Akbari et al., 2016). The thermogram formed at the measurement of the SLN melting point was appeared to be a sharp and narrow peak and the endothermic peak was in the vicinity of GMS solid lipid melting point. In vitro skin penetration study In this penetration study, the solvent used in the receptor compartment was phosphate buffer ph 5.5 to maintain the stability of unstable EGCG compounds at an alkaline ph (ph > 5.5) (Krupkova et al., 2016). The penetration test was analyzed for 12 hours at 12 point intervals. The result of penetration test

5 Dzulhi et al. / Journal of Applied Pharmaceutical Science 8 (08); 2018: conducted yields cumulative EGCG which penetrated for 12 hours from GT-SLN ± μg/cm 2 and GT 4,100 ± 0,054 μg/ cm 2 (see Fig. 4). For the flux value by GT-SLN of ± μg/cm 2.hour and GT of ± μg/cm 2.hour. A comparison of EGCG flux values of GT-SLN with GT can be seen in Figure 5. Fig. 3: DSC thermograms of (a) pure green tea leaves extract, (b) GMS, (c) physical mixture GT-GMS, and (c) GT-loaded SLN. Fig. 4: Cumulative amount (Q) of GT-SLN and GT penetrated across rat skin (n = 3). Table 2: Differential Scanning Calorimetry (DSC) Analysis. Samples Onset ( C) Peak ( C) Enthalpy (J/g) GT GMS Physical Mixture (GT-GMS) GT-SLN These results indicate that GT-SLN preparations had a better penetration rate than those without SLN. The amount of cumulative drug penetrated the skin for 12 hours was very small because SLN persists on the applied skin surface due to the adhesive properties. SLN, when used on the surface of the skin, will form a film layer and form an adhesive layer that covers the skin. Moreover, there will be an increase in hydration of the stratum corneum which will increase the penetration of the drug into the skin layer. In addition, increased penetration is due to the occlusive effects of SLN. This occlusive effect is strongly influenced by particle size in which the properties of occlusive nanoparticles are 15 times more occlusive than microparticles. Where the occlusive properties are better at particle sizes less than 400 nm (Lv et al., 2009; Schafer-Korting et al., 2007). In this study, GT-SLN had a particle size of ± nm (<400 nm), so the formed SLN had an occlusive effect that will lead to increase penetration into the skin layers. CONCLUSION Preparation of SLN using the solvent emulsificationevaporation method has been successfully developed for GT-SLN. The optimum formulations were GT-SLN1 with particle size ± nm; polydispersity index ± 0.05; zeta potential ± 1.29 mv; entrapment efficiency ± 0.443% with spherical shape morphology. In vitro penetration study showed that EGCG formulated in SLN could increase EGCG penetration in the skin layer with higher EGCG flux in GT-SLN cream (1.965 ± μg/cm 2.hour) than in GT cream (0.261 ± μg/ cm 2.hour). It can be concluded that SLN is able to increase the penetration of the drug into the skin and hence SLN can be used as an alternative carrier system for cosmetic preparations. ACKNOWLEDGMENT This research is financially supported by a research grant from National Agency of Drug and Food Control of Republic of Indonesia and Faculty of Pharmacy Universitas Indonesia. CONFLICT OF INTEREST The authors have declared no conflict of interest. Fig. 5: Flux (J) of EGCG from GT-SLN and GT over 12 h using Franz Diffusion cells (n = 3). REFERENCES Aafrin Thasleema S. Green tea as an antioxidant-a short review. J Pharm Sci Res, 2013; 5(9): Akbari J, Saeedi M, Morteza-Semnani K, et al. The design of naproxen solid lipid nanoparticles to target skin layers. Colloids Surfaces B Biointerfaces, 2016; 145: Balguri SP, Adelli GR, Majumdar S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm, 2016; 109: Ekambaram P, Abdul Hasan Sathali A. Formulation and

6 062 Dzulhi et al. / Journal of Applied Pharmaceutical Science 8 (08); 2018: evaluation of solid lipid nanoparticles of ramipril. J Young Pharm, 2011; 3(3): Ganesan P, Narayanasamy D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain Chem Pharm, 2017; 6(May): Jigisha A, Nishant R, Navin K, G. Pankaj. Green tea: A magical herb with miraculous outcomes. Int Res J Pharm, 2012; 3(5): Jose S, Anju SS, Cinu TA, Aleykutty NA, Thomas S, Souto EB. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int J Pharm, 2014; 474(1-2):6-13. Katz LM, Dewan K, Bronaugh RL. Nanotechnology in cosmetics. Food Chem Toxicol, 2015; 85: Kelidari HRR, Saeedi M, Akbari J, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surfaces B Biointerfaces, 2015; 128: Krishnaveni M. Secrets of Epigallocatechin-3-Gallate (EGCG) in Green Tea. J Pharm Res, 2012; 5(12): Krupkova O, Ferguson SJ, Wuertz-Kozak K. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. J Nutr Biochem, 2016; 37:1-12. Lv Q, Yu A, Xi Y, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm, 2009; 372(1-2): Mäder K, Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001; 47(2 3): Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2012; 64(SUPPL.): Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 2002; 54(SUPPL.): Namal Senanayake SPJ. Green tea extract: Chemistry, antioxidant properties and food applications - A review. J Funct Foods, 2013; 5(4): Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 2009; 366(1-2): Patel AR, Velikov KP. Non-covalent interactions of green tea polyphenols: Source of novel colloidal structures. Handb Green Tea, 2013; 9: Scalia S, Trotta V, Bianchi A. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations. Acta Pharm, 2014; 64(2): Schafer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev, 2007; 59(6): Gillbro JM, Olsson MJ. The melanogenesis and mechanisms of skin lightening agents - Existing and new approaches. Int J Cosmet Sci, 2011;33(3): Sinija VR, Mishra HN. Green tea: Health benefits. J Nutr Environ Med, 2008; 17(4): Sun Y, Hung WC, Chen FY, Lee CC, Huang HW. Interaction of tea catechin (-)-epigallocatechin gallate with lipid bilayers. Biophys J, 2009; 96(3): Thakker KD, Chern WH. Development and validation of in vitro release tests for semisolid dosage forms-case study. Dissolution Technol, 2003; 10(2): How to cite this article: Dzulhi S, Anwar E, Nurhayati T. Formulation, Characterization and in vitro Skin Penetration of Green tea (Camellia sinensis L.) Leaves Extract-Loaded Solid Lipid Nanoparticles. J App Pharm Sci, 2018; 8(08):

DEVELOPMENT OF SOLID LIPID NANOPARTICLES OF A WATER SOLUBLE DRUG

DEVELOPMENT OF SOLID LIPID NANOPARTICLES OF A WATER SOLUBLE DRUG Page4813 Indo American Journal of Pharmaceutical Research, 2016 ISSN NO: 2231-6876 DEVELOPMENT OF SOLID LIPID NANOPARTICLES OF A WATER SOLUBLE DRUG Akkshata Parab*, Amrita Bajaj Department of Pharmaceutics,

More information

Preparation and Evaluation of Nano-Structured Lipid Carriers of Azelaic Acid in Topical Formulation (Hydrogel)

Preparation and Evaluation of Nano-Structured Lipid Carriers of Azelaic Acid in Topical Formulation (Hydrogel) Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research; (); -9 Research Article ISSN: 9 X Preparation and Evaluation of Nano-Structured Lipid Carriers of

More information

Preparation and Characterization of Candesartan Cilexetil Solid Lipid Nanoparticulate Capsules

Preparation and Characterization of Candesartan Cilexetil Solid Lipid Nanoparticulate Capsules Research Article Preparation and Characterization of Candesartan Cilexetil Solid Lipid Nanoparticulate Capsules *Surya Kiran Vuddisa, Subramanian S., Sindhu Raavi Department of Pharmaceutics, PSG College

More information

Development and Characterization of Lipid Nanoparticles prepared by Miniemulsion Technique

Development and Characterization of Lipid Nanoparticles prepared by Miniemulsion Technique Development and Characterization of Lipid Nanoparticles prepared by Miniemulsion Technique Clara Patrícia Andrade Lopes Instituto Superior Técnico, Universidade de Lisboa, Portugal clara.cpal@gmail.com

More information

3.1 Background. Preformulation Studies

3.1 Background. Preformulation Studies Preformulation Studies 3.1 Background Delivery of any drug requires a suitable dosage form to get optimum therapeutic effects. The development of such dosage forms fundamental properties of the drug molecule

More information

Study on Targeting and in vitro Anti-oxidation of Baicalin Solid Lipid Nanoparticles

Study on Targeting and in vitro Anti-oxidation of Baicalin Solid Lipid Nanoparticles Ping Y et al. Chinese Herbal Medicines, 212, 4(4): 335-339 335 Study on Targeting and in vitro Anti-oxidation of Baicalin Solid Lipid Nanoparticles PING Yang 1, YU Lian 1, HU Yan-qiu 1, MA Li-na 1, CAO

More information

DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES BY SOLVENT DIFFUSION- EVAPORATION METHOD FOR TOPICAL DELIVERY

DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES BY SOLVENT DIFFUSION- EVAPORATION METHOD FOR TOPICAL DELIVERY IJPSR (2014), Vol. 5, Issue 3 (Research Article) Received on 24 September, 2013; received in revised form, 10 December, 2013; accepted, 17 February, 2014; published 01 March, 2014 DEVELOPMENT AND CHARACTERIZATION

More information

Formulation and Evaluation of Acyclovir Liposomes

Formulation and Evaluation of Acyclovir Liposomes Krishna Mohan Chinnala and Rabinarayan Panigrahy., 217/ Formulation and evaluation of acyclovir RESEARCH ARTICLE International Research Journal of Pharmaceutical and Biosciences Pri -ISSN: 2394-5826 http://www.irjpbs.com

More information

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) June 2010 TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

Anti-Inflammatory Evaluation of NLC (Nanostructured Lipid Carriers) Meloxicam In-Vivo

Anti-Inflammatory Evaluation of NLC (Nanostructured Lipid Carriers) Meloxicam In-Vivo Available online on www.ijddt.com International Journal of Drug Delivery Technology 2017; 7(4); 327-331 doi : 10.25258/ijddt.v7i04.10657 ISSN: 0975 4415 Research Article Anti-Inflammatory Evaluation of

More information

PREPARATION AND CHARACTERIZATION OF LORNOXICAM LOADED SOLID LIPID NANOPARTICLES MADE FROM DIFFERENT LIPIDS

PREPARATION AND CHARACTERIZATION OF LORNOXICAM LOADED SOLID LIPID NANOPARTICLES MADE FROM DIFFERENT LIPIDS Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 5, Suppl 4, 2013 Research Article PREPARATION AND CHARACTERIZATION OF LORNOXICAM LOADED SOLID LIPID NANOPARTICLES

More information

Preparation, Characterization and In vivo Evaluation of Rosuvastatin Calcium Loaded Solid Lipid Nanoparticles

Preparation, Characterization and In vivo Evaluation of Rosuvastatin Calcium Loaded Solid Lipid Nanoparticles Suvarna et al: Preparation, Characterization and In vivo Evaluation of Rosuvastatin Calcium Loaded Solid Lipid Nanoparticles 2779 International Journal of Pharmaceutical Sciences and Nanotechnology Volume

More information

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.

More information

Effect of mole ratio on physicochemical properties of luteolin-loaded phytosome

Effect of mole ratio on physicochemical properties of luteolin-loaded phytosome 2017; 6(12): 96-101 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(12): 96-101 2017 TPI www.thepharmajournal.com Received: 17-10-2017 Accepted: 18-11-2017 Cysilia K Hindarto

More information

Formulation and Evaluation of Nanostructured Lipid Carrier (NLC) For Glimepiride

Formulation and Evaluation of Nanostructured Lipid Carrier (NLC) For Glimepiride Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (7):251-256 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Thatipamula RP., Palem CR., Gannu R., Mudragada S., * Yamsani MR.

Thatipamula RP., Palem CR., Gannu R., Mudragada S., * Yamsani MR. 23 Thatipamula RP., Palem CR., Gannu R., Mudragada S., * Yamsani MR. Received 8 Sept 2010 Revised 30 Jan 2011 Accepted 2 Feb 2011 Domperidone (DOM) is a dopamine- receptor (D 2 ) antagonist, widely used

More information

Chapter - V RESULTS AND DISCUSSION

Chapter - V RESULTS AND DISCUSSION Chapter - V RESULTS AND DISCUSSION ANALYTICAL STUDY SCANNING OF DRUG Pure Ketoconazole was scanned in phosphate buffer saline (PBS) ph 7.4 and 10% methanol between 200 nm and 400 nm using uv-visible spectrophotometer.

More information

THE INFLUENCE OF OILS AND SURFACTANTS ON THE FORMATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS (SNEDDS) CONTAINING THERAPEUTIC PROTEIN

THE INFLUENCE OF OILS AND SURFACTANTS ON THE FORMATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS (SNEDDS) CONTAINING THERAPEUTIC PROTEIN MATERIALS SCIENCE and TECHNOLOGY Edited by Evvy Kartini et.al. THE INFLUENCE OF OILS AND SURFACTANTS ON THE FORMATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS (SNEDDS) CONTAINING THERAPEUTIC PROTEIN

More information

Supporting Information. Maximizing the Supported Bilayer Phenomenon: LCP Liposomes Comprised Exclusively

Supporting Information. Maximizing the Supported Bilayer Phenomenon: LCP Liposomes Comprised Exclusively S-1 Supporting Information Maximizing the Supported Bilayer Phenomenon: LCP Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery Matthew T. Haynes and

More information

Selecting the Primary Emollient to Enhance the Vitamin E- Acetate Skin Penetration

Selecting the Primary Emollient to Enhance the Vitamin E- Acetate Skin Penetration Selecting the Primary Emollient to Enhance the Vitamin E- Acetate Skin Penetration JOSHITA DJAJADISASTRA 1, Sasanti Tarini 2, Sugiyono 1 1 Department of Pharmacy Faculty of Mathematics and Sciences, University

More information

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS 211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability

More information

Studies on the cyclosporin A loaded stearic acid nanoparticles

Studies on the cyclosporin A loaded stearic acid nanoparticles International Journal of Pharmaceutics 200 (2000) 153 159 www.elsevier.com/locate/ijpharm Studies on the cyclosporin A loaded stearic acid Qiang Zhang a, Guoqing Yie a, Yie Li a, Qingsong Yang a, T. Nagai

More information

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012) July 2012 RITONAVIRI COMPRESSI RITONAVIR TABLETS Final text for addition to The International Pharmacopoeia (July 2012) This monograph was adopted at the Forty-sixth WHO Expert Committee on Specifications

More information

Cosmetic Serum Containing Grape (Vitis vinifera L.) Seed Extract Phytosome: Formulation and in vitro Penetration Study

Cosmetic Serum Containing Grape (Vitis vinifera L.) Seed Extract Phytosome: Formulation and in vitro Penetration Study J Young Pharm, 2018; 10(2) Suppl: s51-s55 A multifaceted peer reviewed journal in the field of Pharmacy www.jyoungpharm.org www.phcog.net Original Article Cosmetic Serum Containing Grape (Vitis vinifera

More information

Tamoxifen Drug Loading Solid Lipid Nanoparticles Prepared by Hot High Pressure Homogenization Techniques

Tamoxifen Drug Loading Solid Lipid Nanoparticles Prepared by Hot High Pressure Homogenization Techniques American Journal of Pharmacology and Toxicology 3 (3): 219-224, 2008 ISSN 1557-4962 2008 Science Publications Tamoxifen Drug Loading Solid Lipid Nanoparticles Prepared by Hot High Pressure Homogenization

More information

Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80

Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80 African Journal of Biotechnology Vol. 10(9), pp. 1684-1689, 28 February, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.1667 ISSN 1684 5315 2011 Academic Journals Full

More information

Fluorescent Carbon Dots as Off-On Nanosensor for Ascorbic Acid

Fluorescent Carbon Dots as Off-On Nanosensor for Ascorbic Acid Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2014 Fluorescent Carbon Dots as Off-On Nanosensor for Ascorbic Acid Jun Gong, Xin Lu, Xueqin An*

More information

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 974-434 Vol.2, No.1, pp 341-347, Jan-Mar 1 FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS Kothawade S. N. 1 *, Kadam

More information

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016 Aspartame This monograph was also published in: Compendium of Food Additive

More information

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION http://www.rasayanjournal.com Vol.4, No.3 (2011), 666-672 ISSN: 0974-1496 CODEN: RJCABP DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR IN BULK AND ITS PHARMACEUTICAL FORMULATION V.Kalyan Chakravarthy*

More information

Pelagia Research Library

Pelagia Research Library Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2013, 4(3):8-13 ISSN: 0976-8688 CODEN (USA): PSHIBD Compritrol ATO 888 based solid lipid nanoparticles of cefixime: Formulation

More information

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: ISSN: 2320-2831 Research article Open Access Method development and validation of tenofovir disoproxil fumerate and emtricitabine in combined tablet

More information

Formulation and Evaluation of Solid lipid nanoparticles: Isoniazid

Formulation and Evaluation of Solid lipid nanoparticles: Isoniazid 129 Research Article Formulation and Evaluation of Solid lipid nanoparticles: Isoniazid Umatiya Imran*, Chintan Aundhia, A.K.Seth, Sachin Chauhan, Nirmal Shah Department of pharmacy, Sumandeep Vidhyapeeth

More information

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS December 2009 ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) This monograph was adopted at the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

The Synthesis of modified hydrophobic starch nanoparticles using long chain fatty acids was accomplished. The modified starch nanoparticles were

The Synthesis of modified hydrophobic starch nanoparticles using long chain fatty acids was accomplished. The modified starch nanoparticles were CHAPTER 4 Hydrophobic grafted and crosslinked starch nano particles for drug delivery The Synthesis of modified hydrophobic starch nanoparticles using long chain fatty acids was accomplished. The modified

More information

EASI-EXTRACT BIOTIN Product Code: P82 / P82B

EASI-EXTRACT BIOTIN Product Code: P82 / P82B EASI-EXTRACT BIOTIN Product Code: P82 / P82B Immunoaffinity columns for use in conjunction with HPLC or LC-MS/MS. For in vitro use only. AOAC Official First Action Method 2016.02 P82/V8/23.03.17 www.r-biopharm.com

More information

Mixed Hydrotropy: Novel Science of Solubility Enhancement

Mixed Hydrotropy: Novel Science of Solubility Enhancement Research Paper Mixed Hydrotropy: Novel Science of Solubility Enhancement R. K. MAHESHWARI* AND Y. JAGWANI Shri G. S. Institute of Technology and Science, 23-Park Road, Indore-452 003, Madhya Pradesh, India

More information

FORMULATION AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES FOR TRANSDERMAL DELIVERY OF TESTOSTERONE

FORMULATION AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES FOR TRANSDERMAL DELIVERY OF TESTOSTERONE FORMULATION AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES FOR TRANSDERMAL DELIVERY OF TESTOSTERONE L. K. Omray TIT College of Pharmacy, Bhopal (M.P.) Pin- 462 021, India Email: lkomray@rediffmail.com

More information

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE Int. J. Chem. Sci.: 6(1), 2008, 441-446 A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE S. APPALA RAJU, ARVIND B. KARADI and SHOBHA MANJUNATH HKES s College of Pharmacy,

More information

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019

More information

EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS

EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 72 No. 4 pp. 785ñ789, 2015 ISSN 0001-6837 Polish Pharmaceutical Society PHARMACEUTICAL TECHNOLOGY EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION

More information

Supporting information

Supporting information S1 Supporting information Biodegradable Injectable Polymer Systems Exhibiting Temperature-Responsive Irreversible Sol-to-Gel Transition by Covalent Bond Formation Yasuyuki YOSHIDA 1,2, Keisuke KAWAHARA

More information

World Journal of Pharmaceutical Research

World Journal of Pharmaceutical Research World Journal of Pharmaceutical ReseaRch Volume 3, Issue 3, 4527-4535. Research Article ISSN 2277 715 DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF RAMOSETRON Zarana

More information

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

ISSN: ; CODEN ECJHAO E-Journal of Chemistry  2011, 8(3), ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2011, 8(3), 1275-1279 Simultaneous Determination of Paracetamol, Phenylephrine Hydrochloride, Oxolamine Citrate and Chlorpheniramine

More information

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON Page67 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 SIMPLE QUANTITATIVE METHOD DEVELOPMENT AND VALIDATION OF VALSARTAN IN PUREFORM AND PHARMACEUTICAL DOSAGE FORMS BYUV SPECTROSCOPY

More information

Syringe Pump Application Note AN27. Figure 1: Phase diagram of water showing vapor-liquid relationship for subcritical water

Syringe Pump Application Note AN27. Figure 1: Phase diagram of water showing vapor-liquid relationship for subcritical water Measurement of Aqueous Solubility of Compounds at High Temperature Using a Dynamic Flow Apparatus and a Teledyne Isco Syringe Pump Jerry W. King & Keerthi Srinivas, University of Arkansas, Dept. of Chemical

More information

Emulsions. Purpose of emulsions and of emulsification:

Emulsions. Purpose of emulsions and of emulsification: Pharmacist Ghada Hamid Emulsions Emulsion is a dispersion in which the dispersed phase is composed of small globules of a liquid distributed throughout a vehicle in which it is immiscible. The dispersed

More information

Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS

Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS ISSN 2395-3411 Available online at www.ijpacr.com 238 Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS G. Jyoti Jain 1* and S. Ramachandra Setty 2 1 Department of Pharmacology,

More information

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar

More information

MıCELLES AS NANOSıZED CARRıERS FOR SKıN DELıVERY OF DRUGS. Sevgi Güngör

MıCELLES AS NANOSıZED CARRıERS FOR SKıN DELıVERY OF DRUGS. Sevgi Güngör MıCELLES AS NANOSıZED CARRıERS FOR SKıN DELıVERY OF DRUGS Sevgi Güngör Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology 4 th International Conference on Nanotek&Expo,01-03

More information

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS JChrDD Vol 2 Issue 2 2011: 89-93 ISSN 2249-6785 Journal of Chronotherapy and Drug Delivery Received: August 06, 2011 Accepted: Sep 12, 2011 Original Research Paper FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY

More information

Liposomes in polymer matrix. Stability of liposomes in PEG 400 and PEG 8000 solutions.

Liposomes in polymer matrix. Stability of liposomes in PEG 400 and PEG 8000 solutions. Liposomes in polymer matrix. Stability of liposomes in PEG 400 and PEG 8000 solutions. Magdalena Bajgrowicz 1,2, Jerzy Detyna 2, Marek Langner 1 1 Institute of Biomedical Engineering and Instrumentation,

More information

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

This revision also necessitates a change in the table numbering in the test for Organic Impurities. Methylphenidate Hydrochloride Extended-Release Tablets Type of Posting Notice of Intent to Revise Posting Date 27 Jul 2018 Targeted Official Date To Be Determined, Revision Bulletin Expert Committee Chemical

More information

EFFICIENT PRODUCTION OF SOY-BEAN LECITHIN PLURONIC L64 ENCAPSULATED QUERCETIN PARTICLES IN NANOMETRIC SCALE USING SFEE AND PGSS DRYING PROCESSES

EFFICIENT PRODUCTION OF SOY-BEAN LECITHIN PLURONIC L64 ENCAPSULATED QUERCETIN PARTICLES IN NANOMETRIC SCALE USING SFEE AND PGSS DRYING PROCESSES EFFICIENT PRODUCTION OF SOY-BEAN LECITHIN PLURONIC L64 ENCAPSULATED QUERCETIN PARTICLES IN NANOMETRIC SCALE USING SFEE AND PGSS DRYING PROCESSES György Lévai, Department of Chemical Engineering & Environmental

More information

Lecipro AOCS Lecithin SC Montreal

Lecipro AOCS Lecithin SC Montreal Lecithin Dispersion and Emulsification Demo W. van Nieuwenhuyzen Lecipro Consulting www.lecipro.nl AOCS Lecithin SC - Montreal, April 27-28, 28, 2013 Lecipro AOCS Lecithin SC Montreal 2013 1 Topics Emulsifying

More information

A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS

A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE

More information

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC Principle To measure the relative percentages of the (3R,3 R), (3R,3 S) and (3S,3 S) stereoisomers of zeaxanthin in dietary ingredient and

More information

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms Asian Journal of Chemistry Vol. 22, No. 7 (2010), 5067-5071 RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms A. LAKSHMANA RAO*, G. TARAKA RAMESH and J.V.L.N.S. RAO Department of Pharmaceutical

More information

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data

EVALUATION OF EFFERVESCENT FLOATING TABLETS. 6.7 Mathematical model fitting of obtained drug release data EVALUATION OF EFFERVESCENT FLOATING TABLETS 6.1 Technological characteristics of floating tablets 6.2 Fourier transform infrared spectroscopy (FT-IR) 6.3 Differential scanning calorimetry (DSC) 6.4 In

More information

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form S. LAVANYA* 1, SK. MANSURA BEGUM 1, K. NAGAMALLESWARA RAO 2, K. GAYATHRI DEVI 3 Department of pharmaceutical

More information

HPLC-UV Determination of Abacavir Sulphate in Pharmaceutical Dosage Forms

HPLC-UV Determination of Abacavir Sulphate in Pharmaceutical Dosage Forms Asian Journal of Chemistry Vol. 19, No. 5 (2007), 3412-3416 HPLC-UV Determination of Abacavir Sulphate in Pharmaceutical Dosage Forms A. SHANTA KUMARI*, K. PRAKASH, K.E.V. NAGOJI and M.E.B. RAO Department

More information

Nanopigments For Broad Spectrum Sun Protection. Patricia Aikens NAFTA Technical Services

Nanopigments For Broad Spectrum Sun Protection. Patricia Aikens NAFTA Technical Services Nanopigments For Broad Spectrum Sun Protection Patricia Aikens NAFTA Technical Services UV radiation and the skin UV absorbers Nanopigments Titanium dioxide Zinc Oxide Electromagnetic Radiation Longer

More information

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.4, pp 1736-1744, Oct-Dec 2013 Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin

More information

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 * International Journal of ChemTech Research ISSN : 0974-4290 Vol.1,No.1,pp 16-26, Jan March 2009 A Validated Specific Reverse Phase Liquid Chromatographic Method for the Determination of Valacyclovir in

More information

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION http://www.rasayanjournal.com Vol.4, No.1 (2011), 165-171 ISSN: 0974-1496 CODEN: RJCABP DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR AND ITS PHARMACEUTICAL FORMULATION V. Kalyana Chakravarthy * and

More information

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method ISSN: 0973-4945; CODEN ECJAO E- Chemistry http://www.e-journals.net 2012, 9(1), 340-344 Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by PLC Method V.

More information

Topical Preparations

Topical Preparations Topical Preparations One of the functions of the skin is to protect the internal body components against the external environment and thus to control the passage of chemicals into and out of the body.

More information

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form IJPAR Vol.4 Issue 1 Jan-Mar-2015 Journal Home page: ISSN: 2320-2831 Research article Open Access A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical

More information

4. Determination of fat content (AOAC, 2000) Reagents

4. Determination of fat content (AOAC, 2000) Reagents 94 ANALYTICAL METHODS 1. Determination of moisture content (AOAC, 2000) 1. Dry the empty dish and lid in the oven at 105 C for 3 h and transfer to desiccator to cool. Weigh the empty dish and lid. 2. Weigh

More information

Enhanced delivery methods for greater efficacy

Enhanced delivery methods for greater efficacy On-Line Formulation Training - Anywhere In The World - Enhanced delivery methods for greater efficacy Belinda Carli Director, Institute of Personal Care Science Image showing absorbance in the outer stratum

More information

Shweta Vashist. et al. / International Journal of Biopharmaceutics. 2015; 6(1): International Journal of Biopharmaceutics

Shweta Vashist. et al. / International Journal of Biopharmaceutics. 2015; 6(1): International Journal of Biopharmaceutics 48 e- ISSN 0976-1047 Print ISSN 2229-7499 International Journal of Biopharmaceutics Journal homepage: www.ijbonline.com IJB FORMULATION AND EVALUATION OF PRONIOSOMAL GEL OF DICLOFENAC SODIUM BY USING 3

More information

Preparation and Physicochemical Properties of the Complex of Naringenin with Hydroxypropyl-β-Cyclodextrin

Preparation and Physicochemical Properties of the Complex of Naringenin with Hydroxypropyl-β-Cyclodextrin Molecules 2010, 15, 4401-4407; doi:10.3390/molecules15064401 Communication OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Preparation and Physicochemical Properties of the Complex

More information

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR Efavirenz and ritonavir, two widely prescribed anti retroviral

More information

OPTIMIZATION OF LIPID NANOPARTICLES COMPOSITION FOR SUNSCREEN ENCAPSULATION

OPTIMIZATION OF LIPID NANOPARTICLES COMPOSITION FOR SUNSCREEN ENCAPSULATION U.P.B. Sci. Bull., Series B, Vol. 75, Iss. 3, 213 ISSN 1454-2331 OPTIMIZATION OF LIPID NANOPARTICLES COMPOSITION FOR SUNSCREEN ENCAPSULATION Gabriela NICULAE 1, Ioana LĂCĂTUŞU 2, Nicoleta BADEA 3, Ovidiu

More information

Evaluation of wetting and dispersing additives for the use in waterborne anticorrosive paints. Düsseldorf, , Martin Muth

Evaluation of wetting and dispersing additives for the use in waterborne anticorrosive paints. Düsseldorf, , Martin Muth Evaluation of wetting and dispersing additives for the use in waterborne anticorrosive paints Düsseldorf, 12.09.2013, Martin Muth Content 1. Introduction 2. Functionality and chemistry of wetting and dispersing

More information

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN: IJPSR (2012), Vol. 3, Issue 07 (Research Article) Received on 18 March, 2012; received in revised form 25 April, 2012; accepted 22 June, 2012 A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION

More information

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group FORMULATION CHOICE How and why they are chosen Dr Andy Fowles On behalf of ECPA Specification Expert Group Topics Why formulate? How to identify formulation options Drivers Principle formulation type overview

More information

Formulation and characterization of nanostructured lipid carrier encapsulated Zingiber zerumbet oil using ultrasonication technique

Formulation and characterization of nanostructured lipid carrier encapsulated Zingiber zerumbet oil using ultrasonication technique Formulation and characterization of nanostructured lipid carrier encapsulated Zingiber zerumbet oil using ultrasonication technique N. A. Rosli a, R. Hasham *, b, A. Abdul Aziz c and R. Aziz d Institute

More information

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis Comprehensive Study of SLE as a Sample Preparation Tool for Bioanalysis Wan Wang, Warren Chen, Jerry Wang Bonna-Agela Technologies 179 Southern Street, West TEDA, Tianjin, China Abstract A simple, fast,

More information

SOLID INCLUSION COMPLEXES OF CLASS II IMIDAZOLE DERIVATIVE WITH Β CYCLODEXTRIN. Pradesh.

SOLID INCLUSION COMPLEXES OF CLASS II IMIDAZOLE DERIVATIVE WITH Β CYCLODEXTRIN. Pradesh. Continental J. Pharmaceutical Sciences 1: 1-8, 2007. Wilolud Online Journals, 2007. SOLID INCLUSION COMPLEXES OF CLASS II IMIDAZOLE DERIVATIVE WITH Β CYCLODEXTRIN Tarun Virmani 1, Nayyar Parvez* 1, Suman

More information

Scholars Research Library

Scholars Research Library Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(2): 294-299 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (11):236-242 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

ISSN (Print)

ISSN (Print) Scholars Academic Journal of Pharmacy (SAJP) Sch. Acad. J. Pharm., 2014; 3(3): 240-245 Scholars Academic and Scientific Publisher (An International Publisher for Academic and Scientific Resources) www.saspublisher.com

More information

EFFECT OF SURFACE MODIFICATION OF SOLID LIPID NANOPARTICLES IN BRAIN TARGETING

EFFECT OF SURFACE MODIFICATION OF SOLID LIPID NANOPARTICLES IN BRAIN TARGETING EFFECT OF SURFACE MODIFICATION OF SOLID LIPID NANOPARTICLES IN BRAIN TARGETING THESIS SUBMITTED TO JAMIA HAMDARD (HAMDARD UNIVERSITY) IN FULFILLMENT OF THE REQUIREMENTS FOR THE AWARD OF THE DEGREE OF DOCTOR

More information

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN

More information

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans. Application Note 0066 - Soy for Isoflavones by HPLC As published in The Handbook of Analytical Methods for Dietary Supplements Botanical Name: Glycine max L. Common Names: Soybean Parts of Plant Used:

More information

SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPINE-2-ONE IN THE PRESENCE OF PVP

SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPINE-2-ONE IN THE PRESENCE OF PVP Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 65 No. 4 pp. xxxñyyy, 2008 ISSN 0001-6837 Polish Pharmaceutical Society SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPINE-2-ONE IN THE PRESENCE

More information

Optimisation and Stability Assessment of Solid Lipid Nanoparticles using Particle Size and Zeta Potential

Optimisation and Stability Assessment of Solid Lipid Nanoparticles using Particle Size and Zeta Potential Journal of Physical Science, Vol. 25(1), 59 75, 2014 Optimisation and Stability Assessment of Solid Lipid Nanoparticles using Particle Size and Zeta Potential Rohan Shah, * Daniel Eldridge, Enzo Palombo

More information

EASIMIP TM PATULIN Product Code: P250 / P250B

EASIMIP TM PATULIN Product Code: P250 / P250B EASIMIP TM PATULIN Product Code: P250 / P250B Molecularly imprinted polymer columns for use in conjunction with HPLC. For in vitro use only. P250B/V5/03.09.18 www.r-biopharm.com Contents Page Test Principle...

More information

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph. Nitrofurantoin Capsules Type of Posting Revision Bulletin Posting Date 28 Dec 2018 Official Date 01 Jan 2019 Expert Committee Chemical Medicines Monographs 1 Reason for Revision Compliance In accordance

More information

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1 1. INTRODUCTION 1.1. Sustained Drug delivey: 1-6 It is defined as any drug or dosage form modification that prolongs the therapeutic activity of the drug. The amount of drug in the body decrease slowly

More information

Dhana Lakshmi P. et al. / International Journal of Biopharmaceutics. 2012; 3(2): International Journal of Biopharmaceutics

Dhana Lakshmi P. et al. / International Journal of Biopharmaceutics. 2012; 3(2): International Journal of Biopharmaceutics 70 e- ISSN 0976-1047 Print ISSN 2229-7499 International Journal of Biopharmaceutics Journal homepage: www.ijbonline.com IJB SOLID LIPID NANOPARTICLE SYSTEMS FOR DELIVERY OF DRUGS TO THE BRAIN Dhana Lakshmi.

More information

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT January 2012 RESTRICTED DRAFT PROPOSAL FOR The International Pharmacopoeia LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS (January 2012) DRAFT FOR COMMENT This document was provided by a quality control expert.

More information

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS Int. J. Chem. Sci.: 6(1), 2008, 399-404 REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS S. APPALA RAJU, ARVIND B. KARADI and SHOBHA MANJUNATH HKES s

More information

Atorvastatin Loaded Solidlipid Nanoparticles: Formulation, Optimization, and in - vitro Characterization

Atorvastatin Loaded Solidlipid Nanoparticles: Formulation, Optimization, and in - vitro Characterization IOSR Journal of Pharmacy ISSN: 2250-3013, www.iosrphr.org Volume 2 Issue 5 Sep-Oct 2012 PP.23-32 Atorvastatin Loaded Solidlipid Nanoparticles: Formulation, Optimization, and in - vitro Characterization

More information

FORMULATION AND EVALUATION OF PENTOXIFYLLINE LIPOSOME FORMULATION

FORMULATION AND EVALUATION OF PENTOXIFYLLINE LIPOSOME FORMULATION Digest Journal of Nanomaterials and Biostructures Vol. 4, No. 4, December 2009, p. 857 862 FORMULATION AND EVALUATION OF PENTOXIFYLLINE LIPOSOME FORMULATION U. D. SHIVHARE *, D.U. AMBULKAR, V. B. MATHUR,

More information

STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS

STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS AGRANA STARCH QUALITATIVE OPTIMIZATION OF COSMETIC EMULSIONS WITH CORN PO4 PH B OR RICE NS For many years CORN PO4 PH B and RICE NS (cross-linked

More information

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(1):180-184 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 A simple and sensitive RP-HPLC method for estimation

More information